Back to search results

The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study

Abroad (travel likely)RecruitingPHASE2

Conditions

Kidney Transplant; Complications

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • UNC Eastowne Kidney Transplant Clinic, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Sara Kelley, MPH) · sara_kelley@med.unc.edu · 919-445-2658
    Contact: Study coordinator (Sora Lee, BA) · leesora@email.unc.edu · 919-445-2657
    Contact: Principal Investigator (Amy Mottl, MD, MPH)
    Contact: Principal Investigator (Prabir Roy-Chaudhury, MD, PhD)
    Elizabeth Kotzen, MD, MSCR (Sub-investigator)
    Mark Kleman, DO (Sub-investigator)
    Randal Detwiler, MD (Sub-investigator)
    Charles Jennette, MD (Sub-investigator)
Study leads

  • Amy Mottl, MD, MPH

    Principal Investigator

    University of North Carolina, Chapel Hill

  • Prabir Roy-Chaudhury, MD, PhD

    Principal Investigator

    University of North Carolina, Chapel Hill

View source on ClinicalTrials.gov(opens in a new tab)